Kringle Initiates Phase I Clinical Trial of Recombinant Human HGF for the Treatment of Incurable Neuronal Diseases.

Kringle Initiates Phase I Clinical Trial of Recombinant Human HGF for the Treatment of Incurable Neuronal Diseases.